Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1213 ARTÍCULOS , VIENDO DEL 496 AL 510
Neural computation for rehabilitation
Hu X, Wang Y, Zhao T, Gunduz A.
Biomed Res Int. 2014;2014:603985. doi: 10.1155/2014/603985. Epub 2014 Dec 28.
Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors
Liu C, Cui G, Zhu M, Kang X, Guo H.
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8342-55. eCollection 2014.
For how long should we use symptomatic therapies to treat people with Alzheimer disease?
Rockwood K.
Can J Psychiatry. 2014 Dec;59(12):615-7. doi: 10.1177/070674371405901201.
Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease
Hogan DB.
Can J Psychiatry. 2014 Dec;59(12):618-23. doi: 10.1177/070674371405901202.
Alam MZ, Alam Q, Kamal MA, Abuzenadah AM, Haque A.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):383-90. doi: 10.2174/18715273113126660151.
Autophagy dysfunction and its link to Alzheimer's disease and type II diabetes mellitus
Wilson CM, Magnaudeix A, Yardin C, Terro F.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):226-46. doi: 10.2174/18715273113126660146.
Genomic linkage between Alzheimer's disease and type 2 diabetes
Nedjadi T, Haque A, Alam Q, Gan SH, Chaudhary AG, Abuzenadah AM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):203-12. doi: 10.2174/18715273113126660140.
A molecular bridge: connecting type 2 diabetes and Alzheimer's disease
Ahmed F, Ansari JA, Ansari ZE, Alam Q, Gan SH, Kamal MA, Ahmad E.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):312-21. doi: 10.2174/18715273113126660133.
A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients
Razlighi QR, Stallard E, Brandt J, Blacker D, Albert M, Scarmeas N, Kinosian B, Yashin AI, Stern Y.
J Alzheimers Dis. 2014;38(3):661-8. doi: 10.3233/JAD-131142.
Molinuevo JL, Casado-Naranjo I.
J Alzheimers Dis. 2014;39(2):227-32. doi: 10.3233/JAD-131433.
Change in body mass index before and after Alzheimer's disease onset
Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, Dubois B, Stern Y.
Curr Alzheimer Res. 2014 May;11(4):349-56. doi: 10.2174/1567205010666131120110930.
Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes
Mahboobi H, Golmirzaei J, Gan SH, Jalalian M, Kamal MA.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):543-52. doi: 10.2174/1871527312666131223110147.
Vardarajan BN, Faber KM, Bird TD, Bennett DA, Rosenberg R, Boeve BF, Graff-Radford NR, Goate AM, Farlow M, Sweet RA, Lantigua R, Medrano MZ, Ottman R, Schaid DJ, Foroud TM, Mayeux R; NIA-LOAD/NCRAD Family Study Group.
JAMA Neurol. 2014 Mar;71(3):315-23. doi: 10.1001/jamaneurol.2013.5570.
Sex differences in cognitive impairment and Alzheimer's disease
Li R, Singh M.
Front Neuroendocrinol. 2014 Aug;35(3):385-403. doi: 10.1016/j.yfrne.2014.01.002. Epub 2014 Jan 13.
Narayan MC.
Home Healthc Nurse. 2014 Feb;32(2):130-1. doi: 10.1097/NHH.0000000000000021.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.